• MK-5108 (VX-689): Aurora-A Kinase Inhibition

  2026-08-12

  This scenario-based guide explains how MK-5108 (VX-689), supplied as SKU A4120, can improve the interpretation and reproducibility of Aurora-A-focused viability, proliferation, and cytotoxicity studies. It covers biochemical selectivity, DMSO formulation, assay controls, dose optimization, data interpretation, and practical vendor-selection criteria.

• Aurora A in Retinoblastoma: Evidence for Targeting

  2026-08-12

  This 2024 study identifies Aurora kinase A (AURKA) overexpression as a feature of human retinoblastoma associated with histopathologic high-risk factors and poor chemotherapy response. By combining patient-tissue analysis with genetic and pharmacologic perturbation across experimental models, the investigators provide a rationale for testing AURKA-directed strategies in advanced or refractory disease.

• AMG 487 for Reliable CXCR3 Assays

  2026-08-11

  AMG 487 (SKU B3266) is a selective CXCR3 antagonist for separating receptor-mediated migration, calcium signaling, and macrophage-state effects from nonspecific assay toxicity. This scenario-based guide covers solvent handling, dose selection, interpretation, and practical vendor evaluation using product data and a recent CXCL10–CXCR3 study.

• Ferritin Hybrid Particles for Combination Vaccines

  2026-08-11

  The reference study develops an Escherichia coli-produced ferritin hybrid particle displaying influenza A M2e and SARS-CoV-2 S-protein tandem epitopes in one assembled vaccine platform. In mice, the hybrid particle generated stronger antigen-specific responses than antigen-only or homologous ferritin constructs and produced sera with functional antiviral, binding, and ADCC-related activity.

• HotStart 2X Green qPCR Master Mix for STING Pathway Studies

  2026-08-10

  Build a reproducible SYBR Green workflow for profiling STING, p38 MAPK, inflammatory, and fibrotic transcripts after glaucoma filtration surgery. This practical guide combines assay design, hot-start specificity, RNA-seq validation, and troubleshooting with executable qPCR starting conditions.

• Streptavidin-Cy3 for NPC Metastasis Workflows

  2026-08-09

  Learn how to use Streptavidin-Cy3 as a bright biotin detection reagent across immunohistochemistry, immunofluorescence, in situ hybridization, and flow cytometry. The workflow connects practical fluorescent readouts with the super-enhancer RNA and NPM1/c-Myc/NDRG1 findings reported in nasopharyngeal carcinoma research.

• Cy5.5 NHS Ester for NIR Biomolecule Imaging

  2026-08-08

  Cy5.5 NHS ester enables covalent near-infrared labeling of proteins, peptides, and amine-modified nucleic acids for sensitive analytical and in vivo imaging workflows. This guide combines practical conjugation parameters with a translational use case: tracking mushroom polysaccharide distribution without confusing fluorescent labeling with biological activity.

• Cy5 RNA Labeling Kit: From LLPS to Probe Design

  2026-08-07

  The Cy5 RNA labeling kit K1062 connects controllable fluorescent nucleotide incorporation with mechanistic studies of RNA–protein condensation. Learn how to translate SARS-CoV-2 nucleocapsid phase-separation findings into better probe design, controls, and imaging workflows.

• Cucurbitacin I (JSI-124): Advanced STAT3 Inhibition in Cance

  2026-08-07

  Cucurbitacin I (JSI-124) stands out for its highly selective STAT3 pathway inhibition, enabling researchers to dissect tumor proliferation and survival with precision tools. This guide delivers optimized protocols, troubleshooting advice, and cross-study insights for maximizing the compound’s impact in cancer and neuro-cardiac research models.

• Tetramethylrhodamine Ethyl Ester Perchlorate in Live Mitocho

  2026-08-06

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) empowers real-time visualization of mitochondrial membrane potential with high sensitivity and minimal cytotoxicity, making it essential for interrogating mitochondrial dysfunction in disease models. This article demystifies TMRE's mechanism, offers optimized workflows, and translates new mechanistic insights into practical troubleshooting strategies for advanced mitochondrial fluorescence imaging.

• Topoisomerase I Regulates Satellite DNA Transcription in Euk

  2026-08-06

  The referenced study uncovers Topoisomerase I as an evolutionarily conserved regulator of α-satellite DNA transcription at centromeres, essential for chromosome segregation. This work clarifies mechanisms of non-coding satellite RNA production and its interplay with DNA damage responses, offering new insight for cancer and chromosome biology.

• β-Amanitin: Molecular Mechanisms and Assay Innovations in RN

  2026-08-05

  Discover the molecular intricacies of β-Amanitin as a selective RNA polymerase II inhibitor. This article explores advanced assay strategies, practical protocol guidance, and the latest innovations in detection, offering a distinctive perspective for transcriptional regulation research.

• AMG 487 and CXCR3 Antagonism: Redefining Macrophage Polariza

  2026-08-05

  AMG 487, a selective CXCR3 antagonist, is reshaping strategies for dissecting macrophage polarization and inflammatory regulation. This article integrates mechanistic insights from recent studies with actionable guidance for translational researchers, highlighting protocol parameters, workflow optimization, and translational relevance in inflammation and immune modulation models. The discussion situates AMG 487 within the evolving competitive landscape and lays a forward-looking vision for CXCR3-targeted research.

• CD40 and STING Competition Drives B Cell Activation in ESCC

  2026-08-04

  A recent study elucidates how CD40 and STING competitively bind TRAF2 to regulate IRF4-mediated B cell activation within tertiary lymphoid structures in esophageal squamous cell carcinoma (ESCC). This mechanistic insight refines our understanding of antitumor immunity and highlights new avenues for biomarker and therapeutic strategy development.

• GCG Disrupts SARS-CoV-2 Nucleocapsid LLPS to Inhibit Replica

  2026-08-04

  Zhao et al. elucidate how the SARS-CoV-2 nucleocapsid protein undergoes RNA-induced liquid–liquid phase separation (LLPS), a process critical for viral replication and assembly. The study demonstrates that (-)-gallocatechin gallate (GCG), a green tea polyphenol, can inhibit this LLPS and thereby suppress SARS-CoV-2 replication, offering new mechanistic insights and therapeutic leads.

14736 records 1/983 page Next 12345 下5页 Last page